Compare drug alternatives
Qulipta® Alternatives
Qulipta®
(Atogepant)
Qulipta
-
Migraine
- Emgality®
- Vyepti®
- Aimovig®
- Nurtec ODT®
- Ubrelvy®
Prescription Only
Qulipta is a prescription medication that is used as a preventative treatment for episodic migraines. It is a tablet that is taken once daily. The most common side effects are fatigue, nausea, and constipation.
Qulipta is FDA approved for the following indications: Migraine prevention.
Ajovy®
(Fremanezumab)
Ajovy
-
Migraine
- Emgality®
- Vyepti®
- Aimovig®
- Nurtec ODT®
- Ubrelvy®
Prescription Only
Ajovy is a prescription medication that can be self-injected once a month or once every three months under the skin to prevent migraine headaches. The most commonly reported side effect is injection site reactions. Ajovy does not seem to cause constipation. Additionally, there are no known drug interactions.
Ajovy is FDA approved for the following indications: Migraine prevention.
Dosage & Administration
Administration
Oral
Subcutaneous
Dosing
10 mg, 30 mg, or 60 mg once daily. Severe Renal Impairment or End-Stage Renal Disease: 10 mg once daily.
225 mg monthly or 675 mg every 3 months (as three consecutive injections of 225 mg each)
Latin Shorthand
10mg qd, 30mg qd or 60mg qd
Renal Impairment: 10mg qd
225 mg/mo or 675 mg q3mo
Financial Assistance
Copay
$0
$5
Annual Cap
$6,000
Patient specific maximum benefit.
Assistance Expiration
12 30-day prescription fills
12/31/2023
Generics
No lower-cost generic available
No lower-cost generic available